Keryx Bio's Auryxia shows potential in delaying dialysis in patients with advanced kidney disease [Seeking Alpha]
KERYX BIOPHARMACEUTICALS (KERX)
Last keryx biopharmaceuticals earnings: 11/8 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.keryx.com/investor-overview
Company Research
Source: Seeking Alpha
Keryx Bio's Auryxia shows potential in delaying dialysis in patients with advanced kidney diseaseResults from an open-label investigator-sponsored study assessing Keryx Biopharmaceuticals' (NASDAQ:KERX) Auryxia (ferric citrate) in patients with advanced chronic kidney disease (CKD) showed its potential for delaying the need for dialysis. The data were presented at ERA/EDTA in Copenhagen.The study evaluated ferric citrate compared to standard-of-care (SOC) treatment in late-stage non-dialysis dependent CKD patients who were not expected to start dialysis within eight weeks of study initiation. Participants were randomized 2:1 to receive either a fixed dose of Auryxia (two tablets per meal) or SOC.In the ferric citrate group, 76 of 133 patients completed the nine months of the study. 30 initiated dialysis, 16 terminated early, eight received a transplant and three died.In the SOC group, 29 of 66 patients completed the study. 31 initiated dialysis, four terminated early and two died (dia
Show less
Read more
Impact Snapshot
Event Time:
KERX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KERX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KERX alerts
High impacting KERYX BIOPHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics